Fecal Occult Testing Market - By Test Type (Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test, Immuno-FOB ELISA Test), By End-use (Hospitals, Diagnostic Centers) – Global Forecast, 20232-2032
Published Date: July - 2024 | Publisher: MIR | No of Pages: 240 | Industry: Healthcare | Format: Report available in PDF / Excel Format
View Details Buy Now 2890 Download Sample Ask for Discount Request CustomizationFecal Occult Testing Market Size
Fecal Occult Testing Market size was worth USD 1 billion in 2022 and is poised to record substantial growth at 5.3% CAGR from 2023-2032, driven by the increasing prevalence of rectal & colon cancer.
Hey there! If you've ever heard of a fecal occult test, it's a way for doctors to check your poop for tiny amounts of blood that you can't see. Finding this blood can be a sign of problems in your digestive system, like colon cancer, polyps, or ulcers. To do this test, you'll collect a sample of your poop and give it to your doctor. Then, they'll mix it with chemicals to see if there's any blood hiding in there. If the test comes back positive, it means there's blood in your poop, and your doctor will probably want to do more tests to figure out why. Finding these problems early on makes a big difference in treatment, so this test can be really helpful in keeping you healthy!
| Report Attribute | Details |
|---|---|
| Base Year | 2022 |
| Fecal Occult Testing Market Size in 2022 | USD 1 Billion |
| Forecast Period | 2023 to 2032 |
| Forecast Period 2023 to 2032 CAGR | 7.3% |
| 2032 Value Projection | USD 2 Billion |
| Historical Data for | 2018 to 2022 |
| No. of Pages | 205 |
| Tables, Charts & Figures | 270 |
| Segments covered | Test Type, End-use, and Region |
| Growth Drivers |
|
| Pitfalls & Challenges |
|
Colorectal cancer is becoming more common, and this is why more people are getting fecal occult tests. This type of test is used to find hidden blood in your stool, which can be a sign of colorectal cancer. Fecal occult tests are simple and non-invasive, so they're easy to do in a doctor's office or at home. These tests are also becoming more popular because they're convenient and don't require any special equipment. This makes them ideal for point-of-care testing, which means they can be done right in the doctor's office. As more people opt for non-invasive tests, fecal occult testing is becoming a preferred screening method for colorectal cancer.
COVID-19 Impact
The COVID-19 pandemic had a positive impact on the fecal occult testing market, driving substantial market progress. Heightened healthcare awareness during the pandemic underscored the significance of early disease detection and prevention, aligning well with the non-invasive nature of fecal occult testing. With a focus on minimizing exposure risks, the preference for non-invasive diagnostics surged, making fecal occult testing an attractive option for individuals seeking regular health check-ups. The shift towards point-of-care and remote testing, along with its integration into telemedicine platforms, further boosted its appeal.
Additionally, the pandemic's emphasis on healthcare preparedness elevated the importance of early intervention, positioning fecal occult testing as a key tool in identifying conditions including colorectal cancer in their early stages. These factors collectively indicated a positive trajectory for the market's growth as individuals became more health-conscious and healthcare systems prioritized early detection and prevention strategies.
Fecal Occult Testing Market Trends
Listen up, folks! Bigwigs in government and healthcare are finally waking up to the fact that colon cancer is a big deal. They're rolling out all sorts of cool stuff to help us fight it, like ads that tell us about it, classes that teach us how to prevent it, and even rules that make it easier to get checked out. For real, the CDC and their buddies are on a mission to keep us colon cancer-free. They're spending money on research, doing educational campaigns like "Screen for Life," and giving states the green light to run their own programs. These efforts aren't just making people more aware of the issue, they're also giving doctors the confidence to recommend those handy little tests that check for hidden blood in your poop.
Furthermore, the U.S. Department of Health and Human Services (HHS) announced the allocation of USD 5 million to support community health centers. This funding, provided by HHS's Health Resources and Services Administration, aimed to enhance the accessibility of vital cancer screenings, ensuring equitable access to life-saving screening services. Therefore, the alignment between government initiatives and the market's growth is evident, as these efforts lead to increased demand and utilization of these tests.
Fecal Occult Testing Market Analysis
When it comes to testing for hidden blood in poop (known as fecal occult testing), there are a few different tests available. One popular one is the guaiac FOB stool test, which brought in a whopping $381.3 million in revenue last year. This test has been around for a while and has earned a good name for itself in the medical world. It's also relatively affordable, which helps explain its popularity. Plus, over the years, it's been getting better and better. Doctors and nurses are used to using the guaiac FOB stool test, and it's known for being reliable. It also doesn't cost too much, which makes it a good option for many people. All of these things have helped the guaiac FOB stool test become the go-to choice for fecal occult testing.
When it comes to testing for hidden blood in stool, hospitals, diagnostic centers, and other places all play a role. In 2022, diagnostic centers were like the boss, raking in over 46% of the dough. And they're expected to keep growing like crazy in the years to come. Here's whydiagnostic centers are like the superheroes of medical testing. They've got specialized equipment and skilled docs, so they can find even the tiniest traces of blood in your poop. This makes patients and doctors trust them to get the job done right. And when people trust them, they keep coming back for more.
In addition, their strategic locations in urban and suburban areas bolster accessibility, resulting in increased utilization and market dominance. Therefore, the diagnostic centers' market dominance stems from their specialized focus, technological prowess, convenience, and widespread accessibility, making them pivotal drivers of both market expansion and efficacy in the realm of fecal occult testing.
In the U.S., blood stool tests (fecal occult testing) are a big business, raking in about $353.1 million in 2022. And it's only going to get bigger. The reason? Colon cancer. Sadly, the U.S. has a lot of it. In 2020 alone, there were over 126,000 new cases and over 51,000 deaths. That's where these blood stool tests come in. They're a way to catch colon cancer early, when it's easier to treat. The U.S. is a leader in healthcare, so it's no surprise that they're using these tests more and more. And as the need for colon cancer testing grows, so will the market for these tests.
Furthermore, the nation's concentration of cancer research institutions and proactive education and awareness campaigns further amplify the adoption of these screenings. Ultimately, the U.S.'s leadership in healthcare infrastructure, awareness efforts, advanced technologies, and cancer prevention strategies has positioned it as the market leader, significantly propelling the market trends and efficacy.
Fecal Occult Testing Market Share
Some of the eminent market participants operating in the fecal occult testing market include
- HUMASIS.COM
- CTK Biotech, Inc.
- Biopanda Reagents Ltd
- Biohit Oyj
- CERTEST BIOTEC
- Cenogenics Corporation
- Alfa Scientific Designs, Inc.
- Siemens Healthcare GmbH
- Jant Pharmacal Corporation
- Quidel Corporation
- Wondfo
These market players are undertaking several growth strategies including partnerships, collaborations, acquisitions & mergers, and new product development & launches to strengthen their product portfolio as well as gain a competitive edge over others.
Fecal Occult Testing Industry News
- In November 2022, a completely automatic fecal immunochemical test called Faecal Calprotectin Analyzer “OC-SENSOR Ceres” was launched by Eiken Chemical Co, Ltd. This enabled the company to enhance its product portfolio.
- In January 2022, Boditech Med Inc. declared that they had engaged in a USD 19.2 million supply contract with A. Menarini Diagnostics to expand its product portfolio. Such partnerships enable in accelerating industry expansion.
Fecal Occult Testing market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2018 to 2032 for the following segments
Click here to Buy Section of this Report
By Test Type (USD Million & Units)
- Guaiac FOB stool test
- Immuno-FOB agglutination test
- Lateral flow immuno-FOB test
- Immuno-FOB ELISA test
By End-use (USD Million)
- Hospitals
- Diagnostic centers
- Others
The above information is provided for the following regions and countries
- North America
- U.S.
- Canada
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Switzerland
- The Netherlands
- Denmark
- Poland
- Sweden
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- New Zealand
- Thailand
- Vietnam
- Indonesia
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Chile
- Middle East & Africa
- Saudi Arabia
- South Africa
- UAE
- Turkey
Related Reports
FAQ'S
For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:
Within 24 to 48 hrs.
You can contact Sales team (sales@marketinsightsresearch.com) and they will direct you on email
You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.
Discounts are available.
Hard Copy